.png?width=800&height=200&name=Logos%20(3).png)
Partner Resource Hub: Enabling Joint Account Succcess
Use this resource hub to introduce CancerIQ to your accounts, demonstrate how it complements Myriad testing, and open new doors for program growth. Inside you’ll find quick explainers, sales tools, case studies, and best practices to help your sites launch or expand precision prevention programs with confidence.
Ordering Guides
How To Order Myriad Tests within CancerIQ
Ordering Myriad Precise Oncology Somatic Tests in CancerIQ
Users can now place orders for any of Myriad’s tumor tests in the Testing Tab in CIQ, and produce a pre-filled Myriad Precise TRF by entering information into the Precise TRF Wizard.
Ordering a Myriad Test in CancerIQ
To standardize the experience for ordering a test across our platform, we have removed the DocuSign function for Myriad tests. You will now be able to generate a Myriad Test Requisition Form and have the option to add an e-signature directly through CancerIQ!
Training Videos
Workflow Sample Demos from the AHEAD Program
Generating a survey code in CIQ
Generating a survey code in CIQ | HubSpot Video
Taking the CIQ Survey
Taking the CIQ Survey | HubSpot Video
Generating the intake form and Myriad TRF
Generating the intake form and Myriad Test Request Form | HubSpot Video
CancerIQ & Myriad
Shared Partnership Successes
Featured Case Studies of Key Customers Using Myriad & CancerIQ
Whether expanding specialist capacity or improving adherence to payer-supported screenings, leading health systems choose CancerIQ to identify at-risk patients earlier, streamline personalized care pathways and drive better clinical and financial outcomes. See how health systems are using CancerIQ.
Adventist (Systemwide)
Adventist Health used CancerIQ to expand specialist capacity and navigate high-risk patients across the health system, resulting in a $15 million increase in revenue over 5 years. #healthsystem
Adventist Health St. Helena
Adventist Health St. Helena Women’s Center achieved a 25% increase in breast cancer screening compliance and a 290% increase in colon cancer screening compliance. Adventist White Memorial Cancer Center tripled annual genetic testing with CancerIQ — reaching over 150 patients per year, 75% of whom are from underserved patient populations. #womenshealth
Dignity Health
Dignity Health, part of CommonSpirit Health, saw a 10X increase in genetic testing after using CancerIQ to offer services at the point-of-care in obstetrics. Now the health system is expanding across more locations and specialties, including primary care and gastroenterology. #genetics
Methodist Jennie Edmundson
Within the first year of CancerIQ implementation, Jennie Edmundson’s early data suggests the technology could be driving a shift toward earlier detection of breast cancer at the NAPBC accredited center. #breastcenter
Featured Customer Webinar Series
Phoenix-based Dignity Health Cancer Institute, now part of the CommonSpirit Health network, wanted to expand access to cancer genetic testing and counseling with telegenetics, but was limited to the bandwidth of a single genetic counselor. Dignity Health turned to CancerIQ to automate administrative processes, create more capacity for high-risk patients, and demonstrate program value. In the first year with CancerIQ, Dignity Health saw a two-fold increase in patient volume, increased retention of high-risk patients and secured long-term funding for continued growth of the program.
ASHLEY NAVARRO, MS, CGC | Dignity Health Cancer Institute
Telegenetic Counselor, CGC
RACHEL MCCONACHIE, RN, BSN, MSN | Division Director, Oncology
Oncology Service Line Administrator
About CancerIQ
Featured CancerIQ Product & Services Resources
Solution 1-Pager
For Health Systems
For Oncology
For Breast Centers
For Women's Health
Webinar Series
Quarterly Product Webinars
Q1 2025: Recording & Slides
Q4 2024: Recording & Slides
Branding
Looking for brand assets?
Visit our Brand Page (with password Prevent123) for additional branding assets, including our logos.
Webinar Series
WATCH: Unlocking the VALUE of Genetics with Real Data and Real ROI
-1.png?width=150&height=150&name=Speaker%20Headshots%20(4)-1.png)
We know that cancer genetic risk assessment (GCRA) and a risk-based approach to cancer prevention and early detection are essential for clinical success, and even payers acknowledge the financial benefits. So why isn’t it happening at scale in provider organizations? Many genetics and high-risk programs lack the financial resources or staffing to deliver these services broadly. To help you make a strong business case to leadership in 2025, we’re offering an on-demand webinar series that will highlight both the clinical and financial benefits of comprehensive GCRA programs.